Revenue: The sum of all revenue fields included for a company's operating activities.
Novozymes A/S (NVZMY) had Revenue of $1.31B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$1.31B |
$233.03M |
|
$567.18M |
|
$742.85M |
|
$997.77M |
|
$312.26M |
|
$-11.59M |
|
$300.68M |
|
$300.68M |
|
$233.03M |
|
$233.03M |
|
$233.03M |
|
$233.03M |
|
$312.26M |
|
$312.26M |
|
463.02M |
|
463.02M |
|
$0.50 |
|
$0.50 |
|
| Balance Sheet Financials | |
$2.39B |
|
$3.58B |
|
$16.94B |
|
$19.34B |
|
$1.43B |
|
$3.42B |
|
$5.13B |
|
$6.56B |
|
-- |
|
$-256.79M |
|
$12.78B |
|
-- |
|
| Cash Flow Statement Financials | |
$195.57M |
|
$-108.96M |
|
$-30.31M |
|
$322.21M |
|
$382.95M |
|
$60.74M |
|
-- |
|
$-310.27M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.67 |
|
-- |
|
-- |
|
0.21 |
|
0.29 |
|
56.71% |
|
23.84% |
|
23.84% |
|
-- |
|
22.95% |
|
17.79% |
|
$103.00M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.61 |
|
1.23 |
|
72.94 |
|
-- |
|
-90.75% |
|
1.21% |
|
1.44% |
|
-- |
|
$0.22 |
|
$0.42 |
|